Biogen Inc.BIIBNASDAQ
Loading
SG&A Expense Growth AcceleratingAccelerating
Percentile Rank82
3Y CAGR+3.7%
5Y CAGR-18.8%
Year-over-Year Change
Year-over-year SG&A expense growth
3Y CAGR
+3.7%/yr
Quarterly compound
5Y CAGR
-18.8%/yr
Recent acceleration
Percentile
P82
Within normal range
vs 5Y Ago
0.4x
Contraction
Streak
3 qtr
Consecutive growthAccelerating
| Period | Value |
|---|---|
| Q4 2025 | 14.83% |
| Q3 2025 | 2.32% |
| Q2 2025 | 1.17% |
| Q1 2025 | -15.34% |
| Q4 2024 | 17.65% |
| Q3 2024 | 4.83% |
| Q2 2024 | -4.84% |
| Q1 2024 | -4.90% |
| Q4 2023 | -19.21% |
| Q3 2023 | 40.30% |
| Q2 2023 | -11.32% |
| Q1 2023 | -5.20% |
| Q4 2022 | 13.30% |
| Q3 2022 | -1.62% |
| Q2 2022 | -9.81% |
| Q1 2022 | -20.56% |
| Q4 2021 | 22.18% |
| Q3 2021 | 2.64% |
| Q2 2021 | 7.11% |
| Q1 2021 | -26.83% |
| Q4 2020 | 41.89% |
| Q3 2020 | 3.24% |
| Q2 2020 | -2.63% |
| Q1 2020 | -15.10% |
| Q4 2019 | 21.10% |
| Q3 2019 | -2.58% |
| Q2 2019 | 0.26% |
| Q1 2019 | -4.41% |
| Q4 2018 | 19.33% |
| Q3 2018 | -3.58% |
| Q2 2018 | 2.97% |
| Q1 2018 | -9.64% |
| Q4 2017 | 27.89% |
| Q3 2017 | 0.93% |
| Q2 2017 | -13.82% |
| Q1 2017 | 0.65% |
| Q4 2016 | 7.09% |
| Q3 2016 | -6.03% |
| Q2 2016 | -0.99% |
| Q1 2016 | -14.70% |